Intrinsiqs

Is Amneal Pharmaceuticals, Inc. overvalued?

Amneal Pharmaceuticals, Inc. (AMRX) looks undervalued — trading about 53% below its fair value.

Undervalued
Current price $19.77 Fair value $30.33
Price
$19.77
Fair value
$30.33
Current P/E
22.0
Normal P/E
33.7
Market cap
$6.31B
Dividend yield
0.0%
Return on equity
-326.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares AMRX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group Incorporated